Updated just now · Live
Stock analysis, price data, and AI-powered insights for Bio-Techne (TECH).
Bio-Techne operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for TECH.
How to read insider trading filings
Johnson & Johnson
UnitedHealth Group Incorporated
AbbVie Inc.
Merck & Co., Inc.
Eli Lilly and Company
Thermo Fisher Scientific Inc.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). TECH Stock Intelligence Report. [stoxpulse.com/stocks/tech]
Disclaimer: The information on this page about Bio-Techne (TECH) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Bio-Techne.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No earnings data available.
Bio-Techne's Q3 Earnings on Deck: What's in Store ...
1d ago
These S&P500 stocks are moving in today's session
6d ago
StoxPulse AI results for TECH: Pulse Score 49/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$8.13B
P/E Ratio
110.4
EPS
$0.24
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sector
Healthcare
Industry
Life Sciences Tools & Services
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-24
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-24
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-16
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-04-07
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
2026-03-04